Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Immunogenic cell death (ICD) has emerged as a key component of therapy-induced anti-tumor immunity. Over the past few years, ICD was found to play a pivotal role in a wide variety of novel and existing treatment modalities. The clinical application of these techniques in cancer treatment is still in...

Descripción completa

Detalles Bibliográficos
Autores principales: Decraene, Brecht, Yang, Yihan, De Smet, Frederik, Garg, Abhishek D., Agostinis, Patrizia, De Vleeschouwer, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866117/
https://www.ncbi.nlm.nih.gov/pubmed/35046546
http://dx.doi.org/10.1038/s41435-021-00161-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866117/
https://www.ncbi.nlm.nih.gov/pubmed/35046546
http://dx.doi.org/10.1038/s41435-021-00161-5

Ejemplares similares